These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 29108133

  • 1. Targeted delivery of microRNA-199a-3p using self-assembled dipeptide nanoparticles efficiently reduces hepatocellular carcinoma in mice.
    Varshney A, Panda JJ, Singh AK, Yadav N, Bihari C, Biswas S, Sarin SK, Chauhan VS.
    Hepatology; 2018 Apr; 67(4):1392-1407. PubMed ID: 29108133
    [Abstract] [Full Text] [Related]

  • 2. MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells.
    Fornari F, Milazzo M, Chieco P, Negrini M, Calin GA, Grazi GL, Pollutri D, Croce CM, Bolondi L, Gramantieri L.
    Cancer Res; 2010 Jun 15; 70(12):5184-93. PubMed ID: 20501828
    [Abstract] [Full Text] [Related]

  • 3. MiR-199a-modified exosomes from adipose tissue-derived mesenchymal stem cells improve hepatocellular carcinoma chemosensitivity through mTOR pathway.
    Lou G, Chen L, Xia C, Wang W, Qi J, Li A, Zhao L, Chen Z, Zheng M, Liu Y.
    J Exp Clin Cancer Res; 2020 Jan 02; 39(1):4. PubMed ID: 31898515
    [Abstract] [Full Text] [Related]

  • 4. Silence of lncRNA HEIH suppressed liver cancer cell growth and metastasis through miR-199a-3p/mTOR axis.
    Ma Y, Cao D, Li G, Hu J, Liu X, Liu J.
    J Cell Biochem; 2019 Oct 02; 120(10):17757-17766. PubMed ID: 31144384
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-199a-3p regulates endometrial cancer cell proliferation by targeting mammalian target of rapamycin (mTOR).
    Wu D, Huang HJ, He CN, Wang KY.
    Int J Gynecol Cancer; 2013 Sep 02; 23(7):1191-7. PubMed ID: 23851675
    [Abstract] [Full Text] [Related]

  • 6. MiR-199a-5p suppresses tumorigenesis by targeting clathrin heavy chain in hepatocellular carcinoma.
    Huang GH, Shan H, Li D, Zhou B, Pang PF.
    Cell Biochem Funct; 2017 Mar 02; 35(2):98-104. PubMed ID: 28261837
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Anti-invasion and anti-migration effects of miR-199a-3p in hepatocellular carcinoma are due in part to targeting CD151.
    Kim JH, Badawi M, Park JK, Jiang J, Mo X, Roberts LR, Schmittgen TD.
    Int J Oncol; 2016 Nov 02; 49(5):2037-2045. PubMed ID: 27599545
    [Abstract] [Full Text] [Related]

  • 13. The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma.
    Kinose Y, Sawada K, Nakamura K, Sawada I, Toda A, Nakatsuka E, Hashimoto K, Mabuchi S, Takahashi K, Kurachi H, Lengyel E, Kimura T.
    Oncotarget; 2015 May 10; 6(13):11342-56. PubMed ID: 25839163
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. MicroRNA-34c-3p promotes cell proliferation and invasion in hepatocellular carcinoma by regulation of NCKAP1 expression.
    Xiao CZ, Wei W, Guo ZX, Zhang MY, Zhang YF, Wang JH, Shi M, Wang HY, Guo RP.
    J Cancer Res Clin Oncol; 2017 Feb 10; 143(2):263-273. PubMed ID: 27704267
    [Abstract] [Full Text] [Related]

  • 16. PLGA-based dual targeted nanoparticles enhance miRNA transfection efficiency in hepatic carcinoma.
    Cai C, Xie Y, Wu L, Chen X, Liu H, Zhou Y, Zou H, Liu D, Zhao Y, Kong X, Liu P.
    Sci Rep; 2017 Apr 07; 7():46250. PubMed ID: 28387375
    [Abstract] [Full Text] [Related]

  • 17. Arginine-α, β-dehydrophenylalanine Dipeptide Nanoparticles for pH-Responsive Drug Delivery.
    Singh PK, Chibh S, Dube T, Chauhan VS, Panda JJ.
    Pharm Res; 2018 Jan 16; 35(2):35. PubMed ID: 29362936
    [Abstract] [Full Text] [Related]

  • 18. Lentivirus-mediated overexpression of microRNA-199a inhibits cell proliferation of human hepatocellular carcinoma.
    Jia XQ, Cheng HQ, Qian X, Bian CX, Shi ZM, Zhang JP, Jiang BH, Feng ZQ.
    Cell Biochem Biophys; 2012 Jan 16; 62(1):237-44. PubMed ID: 21847633
    [Abstract] [Full Text] [Related]

  • 19. MiR-199a-3p enhances cisplatin sensitivity of cholangiocarcinoma cells by inhibiting mTOR signaling pathway and expression of MDR1.
    Li Q, Xia X, Ji J, Ma J, Tao L, Mo L, Chen W.
    Oncotarget; 2017 May 16; 8(20):33621-33630. PubMed ID: 28422725
    [Abstract] [Full Text] [Related]

  • 20. miR-199a-3p inhibits cell proliferation and induces apoptosis by targeting YAP1, suppressing Jagged1-Notch signaling in human hepatocellular carcinoma.
    Ren K, Li T, Zhang W, Ren J, Li Z, Wu G.
    J Biomed Sci; 2016 Nov 10; 23(1):79. PubMed ID: 27832779
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.